People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| I-O Urology Corp | — | Other | Series B | $16.0M | $113.1M | 2023 |
| HealthScripts of America - Oklahoma City, LLC | — | Pharmaceuticals | Pre-Seed | $200K | $9.5M | 2013 |
Brad Rouse at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brad Rouse on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kamran Nezami | 1 | 15 |
| David Adair | 1 | 7 |
| John Green | 1 | 5 |
| Brent Laing | 1 | 2 |
| Britton Garrett | 1 | 1 |
| Josh Eckelberry | 1 | 1 |
| David Gilliam | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.